4.3. Tyrosinase Enzymatic Assay

KH Katarzyna Hałdys
WG Waldemar Goldeman
NA Natalia Anger-Góra
JR Joanna Rossowska
RL Rafał Latajka
ask Ask a question
Favorite

The tyrosinase enzymatic assay was performed as described in our previous papers [20,21] using l-3,4-dihydroxyphenylalanine (l-DOPA) (Sigma-Aldrich, Taufkirchen, Germany) as a substrate. l-DOPA was dissolved in a 0.15 mM phosphoric (V) acid solution to a concentration of 5 mM. All TSCs were dissolved in DMSO to a concentration of 50 mM and then diluted in sodium phosphate buffer (0.1 M, pH 6.8) to test concentrations (DMSO concentrations in final reaction mixtures did not exceeded 1%).

The isolated tyrosinase solution (0.5 mg/mL, 40,000 U/mg) was diluted 10 times in sodium phosphate buffer (0,1 M, pH 6.8). First, 10 µL of the diluted enzyme solution was preincubated with TSC solutions (5 min at 25 °C). The optimal ionic strength and pH for tyrosinase activity were provided by 0.1 M sodium phosphate buffer (pH 6.8).

After the solution of l-DOPA was added, monitoring of the reaction was immediately started by measuring the change in absorbance of the color product (dopachrome) for 10 min (λ = 475 nm, 25 °C) using Molecular Devices SpectraMax Plus 384 Microplate Reader. The control sample contained the same reagents as the test samples except for the substrate. Kojic acid (Sigma-Aldrich, Taufkirchen, Germany), a positive control, was treated the same way as the other inhibitors.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A